Methylation status and neurodegenerative markers in Parkinson disease

R Obeid, A Schadt, U Dillmann, P Kostopoulos… - Clinical …, 2009 - academic.oup.com
Background: Increased concentrations of plasma total homocysteine (tHcy) have been
associated with age-related diseases, including dementia, stroke, and Parkinson disease …

Folate and Methylation Status in Relation to Phosphorylated Tau Protein(181P) and β-Amyloid(1–42) in Cerebrospinal Fluid

R Obeid, M Kasoha, JP Knapp, P Kostopoulos… - Clinical …, 2007 - academic.oup.com
Background: Increased plasma total homocysteine (tHcy) is a risk factor for neurological
diseases, but the underlying pathophysiology has not been adequately explained. Methods …

Elevated plasma homocysteine level in patients with Parkinson disease: motor, affective, and cognitive associations

PE O'Suilleabhain, V Sung, C Hernandez… - Archives of …, 2004 - jamanetwork.com
Background An elevated plasma homocysteine (Hcy) level has been prospectively
associated with an increased risk of vascular and degenerative dementias. An Hcy elevation …

Plasma Homocysteine and l-DOPA Metabolism in Patients with Parkinson Disease

F Blandini, R Fancellu, E Martignoni… - Clinical …, 2001 - academic.oup.com
Homocysteine is formed by demethylation of methionine and is involved in transmethylation
mechanisms. Hyperhomocysteinemia is associated with a wide range of clinical …

Elevated levels of methylmalonate and homocysteine in Parkinson's disease, progressive supranuclear palsy and amyotrophic lateral sclerosis

J Levin, K Bötzel, A Giese, M Vogeser… - Dementia and geriatric …, 2010 - karger.com
Abstract Background/Aims: Increasing evidence suggests that elevated levels of
homocysteine (Hcy) and methylmalonate (MMA) may be involved in the pathogenesis of …

Association of homocysteine with plasma amyloid β protein in aging and neurodegenerative disease

MC Irizarry, ME Gurol, S Raju, R Diaz-Arrastia… - Neurology, 2005 - AAN Enterprises
Background: Elevated plasma total homocysteine (tHcy) is a risk factor for cardiovascular
disease and is reported to be an independent risk factor for Alzheimer disease (AD) and …

Homocysteine: a biomarker in neurodegenerative diseases

W Herrmann, R Obeid - Clinical chemistry and laboratory medicine, 2011 - degruyter.com
Diseases of the central nervous system are found in patients with severe
hyperhomocysteinemia (HHcy). Epidemiological studies show a positive, dose-dependent …

Homocysteine metabolism and cerebrospinal fluid markers for Alzheimer's disease

J Popp, P Lewczuk, M Linnebank… - Journal of …, 2009 - content.iospress.com
Disturbed homocysteine metabolism is a risk factor for Alzheimer's disease (AD) and may
contribute to the disease pathophysiology by increasing both amyloid-β (Aβ) production and …

Clinical significance of homocysteine (hcy) on dementia in Parkinson's disease (PD)

IU Song, JS Kim, IS Park, YD Kim, HJ Cho… - Archives of gerontology …, 2013 - Elsevier
Cognitive dysfunction and dementia are common non-motor symptoms of PD. hcy has
various neuronal and endothelial cellular toxicities. The clinical relevance of the levodopa …

Plasma homocysteine concentration relates to the severity but not to the duration of Alzheimer's disease

K Nilsson, L Gustafson… - International journal of …, 2004 - Wiley Online Library
Background It has been reported that plasma tHcy concentration is elevated in patients with
Alzheimer's disease (AD) and relates to the progress or the development of AD. In the …